GSR expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.499200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.071800E-01
Normal-vs-Stage2
9.172600E-01
Normal-vs-Stage3
4.020200E-01
Normal-vs-Stage4
4.772200E-01
Stage1-vs-Stage2
7.084600E-01
Stage1-vs-Stage3
4.096600E-01
Stage1-vs-Stage4
6.779800E-01
Stage2-vs-Stage3
3.348400E-01
Stage2-vs-Stage4
3.070200E-01
Stage3-vs-Stage4
1.710440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.995800E-01
Normal-vs-AfricanAmerican
4.302400E-01
Normal-vs-Asian
8.639200E-01
Caucasian-vs-AfricanAmerican
1.147430E-01
Caucasian-vs-Asian
6.587600E-01
AfricanAmerican-vs-Asian
4.404800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.160800E-01
Normal-vs-Female
9.989000E-01
Male-vs-Female
6.758000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.523400E-01
Normal-vs-Age(41-60Yrs)
7.343800E-01
Normal-vs-Age(61-80Yrs)
9.877400E-01
Normal-vs-Age(81-100Yrs)
6.414800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.097000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.947600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.531200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.845800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.100370E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.223400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.107000E-01
Normal-vs-Daily Drinker
3.903000E-01
Normal-vs-Weekly Drinker
8.939200E-01
Normal-vs-Occasional Drinker
9.096000E-01
Normal-vs-Social Drinker
7.897400E-01
Non Drinker-vs-Daily Drinker
1.682190E-01
Non Drinker-vs-Weekly Drinker
6.409400E-01
Non Drinker-vs-Occasional Drinker
6.551200E-01
Non Drinker-vs-Social Drinker
4.893200E-01
Daily Drinker-vs-Weekly Drinker
1.109580E-01
Daily Drinker-vs-Occasional Drinker
7.510300E-02
Daily Drinker-vs-Social Drinker
4.744200E-02
Weekly Drinker-vs-Occasional Drinker
9.364200E-01
Weekly Drinker-vs-Social Drinker
8.823600E-01
Occasional Drinker-vs-Social Drinker
7.894600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.285400E-01
Normal-vs-Grade 2
4.046100E-02
Normal-vs-Grade 3
3.324200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.971200E-01
Grade 1-vs-Grade 3
4.162400E-01
Grade 1-vs-Grade 4
2.285400E-01
Grade 2-vs-Grade 3
9.913600E-01
Grade 2-vs-Grade 4
4.046100E-02
Grade 3-vs-Grade 4
3.324200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.399400E-01
Normal-vs-NonDiabetic
9.577800E-01
Diabetic-vs-NonDiabetic
2.361000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.722000E-01
Normal-vs-NoPancreatitis
9.868400E-01
Pancreatitis-vs-NoPancreatitis
3.739200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.976400E-01
Normal-vs-N1
9.012200E-01
N0-vs-N1
7.315200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.699600E-01
Normal-vs-TP53-NonMutant
7.593000E-01
TP53-Mutant-vs-TP53-NonMutant
7.705600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
